Aveo Pharmaceuticals
(NASDAQ) AVEO
Aveo Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$90.90M
Net Income (TTM)
$40.52M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AVEO News
AVEO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aveo Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
115
CEO
Michael P. Bailey, MBA
Website
www.aveooncology.comHeadquarters
Boston, MA 02108, US
AVEO Financials
Key Financial Metrics (TTM)
Gross Margin
88%
Operating Margin
-1%
Net Income Margin
-2%
Return on Equity
-2%
Return on Capital
-57%
Return on Assets
-58%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$34.14M
Operating Income
$49.55M
EBITDA
$57.39M
Operating Cash Flow
$57.26M
Capital Expenditure
$0.00
Free Cash Flow
$57.26M
Cash & ST Invst.
$70.54M
Total Debt
$11.00K
Aveo Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$30.45M
+100.7%
Gross Profit
$26.48M
+97.2%
Gross Margin
86.98%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
114
N/A
Net Income
$4.36M
+57.9%
EBITDA
$2.15M
+76.6%
Quarterly Fundamentals
Net Cash
$38.72M
-36.1%
Accounts Receivable
$19.76M
+107.9%
Inventory
$1.11M
-11.7%
Long Term Debt
$27.18M
-17.7%
Short Term Debt
$11.49M
+3084.2%
Return on Assets
-58.07%
N/A
Return on Invested Capital
-57.22%
N/A
Free Cash Flow
$194.00K
+102.4%
Operating Cash Flow
$194.00K
+102.4%